Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 17
Phase 21

Trial Status

Completed3
Recruiting1
Terminated2
Other1

Role Distribution

Principal Investigator7
PI Rate100%

Activity Timeline

Clinical Trials (7)

NCT05734560Phase 1/2Recruiting
D2C7-IT and 2141-V11 in Newly Diagnosed GBM Patients
Newly Diagnosed MGMT Unmethylated Glioblastoma
PrincipalinvestigatorStart date: 2023-09-06
NCT03299309Phase 1Active Not Recruiting
PEP-CMV in Recurrent MEdulloblastoma/Malignant Glioma
Malignant GliomaRecurrent Brain Tumor, ChildhoodRecurrent Medulloblastoma
PrincipalinvestigatorStart date: 2018-06-29
NCT03283631Phase 1Terminated
Intracerebral EGFR-vIII CAR-T Cells for Recurrent GBM
Recurrent GlioblastomaRecurrent Gliosarcoma
PrincipalinvestigatorStart date: 2018-05-30
NCT03043391Phase 1Completed
Phase 1b Study PVSRIPO for Recurrent Malignant Glioma in Children
Anaplastic AstrocytomaAnaplastic OligoastrocytomaAnaplastic Oligodendroglioma+8 more
PrincipalinvestigatorStart date: 2017-11-07
NCT02664363Phase 1Terminated
EGFRvIII CAR T Cells for Newly-Diagnosed WHO Grade IV Malignant Glioma
GlioblastomaGliosarcoma
PrincipalinvestigatorStart date: 2017-02-01
NCT01491893Phase 1Completed
PVSRIPO for Recurrent Glioblastoma (GBM)
GBMGlioblastomaGlioma+1 more
PrincipalinvestigatorStart date: 2012-04-25

Research Network

Collaboration Network

4 collaborators·3 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Darell Bigner, MD, PhD

Istari Oncology, Inc.

Very Similar
2 trials

Shared therapeutic areas:

Anaplastic AstrocytomaAnaplastic OligoastrocytomaAnaplastic Oligodendroglioma+8 more

Worked with same sponsors:

Duke UniversityIstari Oncology, Inc.+2 more
Collaborated on 1 trial
Similarity Score114%

David Ashley, MBBS, FRACP, PhD

Duke University

Moderately Similar
2 trials

Shared therapeutic areas:

GlioblastomaRecurrent GlioblastomaRecurrent Gliosarcoma

Worked with same sponsors:

Annias Immunotherapeutics, Inc.Duke Cancer Institute+2 more
Collaborated on 1 trial
Similarity Score34%

David Ashley, MBBS, FRACP, PhD

Duke University Hospital

Related
1 trials

Shared therapeutic areas:

GlioblastomaGliosarcoma

Worked with same sponsors:

Daniel Landi
Collaborated on 1 trial
Similarity Score24%

Thomas Kaley, MD

Memorial Sloan Kettering Cancer Center

Related
9 trials

Shared therapeutic areas:

GlioblastomaMalignant GliomaAnaplastic Astrocytoma+3 more

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score8%

Sabine Mueller, MD, PhD, MAS

University of California, San Francisco

Related
10 trials

Shared therapeutic areas:

GliomaMedulloblastoma RecurrentEpendymoma+3 more

Worked with same sponsors:

Solving Kids' Cancer
Similarity Score8%

Maryam Fouladi, MD

Nationwide Children's Hospital

Related
10 trials

Shared therapeutic areas:

Anaplastic AstrocytomaGlioblastomaMedulloblastoma+1 more

Worked with same sponsors:

Duke University
Similarity Score5%

Steven Chmura, MD

University of Chicago

Related
5 trials

Shared therapeutic areas:

GBMGliomaMalignant Glioma
Similarity Score4%

Jeffrey Raizer, MD

Northwestern University

Related
8 trials

Shared therapeutic areas:

Malignant GliomaGBMRecurrent Glioblastoma

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score4%

Steven A Rosenberg, M.D.

National Cancer Institute (NCI)

Related
32 trials

Shared therapeutic areas:

GlioblastomaGliosarcomaMalignant Glioma

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score4%

Giselle Sholler, MD

Beat Childhood Cancer at Atrium Health

Related
10 trials

Shared therapeutic areas:

MedulloblastomaEpendymomaGlioma
Similarity Score4%

Publications (0)

No publications found for this investigator.

Clinical Trials (7)

Showing 7 of 7 trials

NCT05734560Phase 1/2PrincipalInvestigator

D2C7-IT and 2141-V11 in Newly Diagnosed GBM Patients

Newly Diagnosed MGMT Unmethylated Glioblastoma
Recruiting
NCT03615404Phase 1PrincipalInvestigator

Cytomegalovirus (CMV) RNA-Pulsed Dendritic Cells for Pediatric Patients and Young Adults With WHO Grade IV Glioma, Recurrent Malignant Glioma, or Recurrent Medulloblastoma

GlioblastomaMalignant GliomaMedulloblastoma Recurrent+3 more
Completed
NCT03299309Phase 1PrincipalInvestigator

PEP-CMV in Recurrent MEdulloblastoma/Malignant Glioma

Malignant GliomaRecurrent Brain Tumor, ChildhoodRecurrent Medulloblastoma
Active Not Recruiting
NCT03283631Phase 1PrincipalInvestigator

Intracerebral EGFR-vIII CAR-T Cells for Recurrent GBM

Recurrent GlioblastomaRecurrent Gliosarcoma
Terminated
NCT03043391Phase 1PrincipalInvestigator

Phase 1b Study PVSRIPO for Recurrent Malignant Glioma in Children

Anaplastic AstrocytomaAnaplastic OligoastrocytomaAnaplastic Oligodendroglioma+8 more
Completed
NCT02664363Phase 1PrincipalInvestigator

EGFRvIII CAR T Cells for Newly-Diagnosed WHO Grade IV Malignant Glioma

GlioblastomaGliosarcoma
Terminated
NCT01491893Phase 1PrincipalInvestigator

PVSRIPO for Recurrent Glioblastoma (GBM)

GBMGlioblastomaGlioma+1 more
Completed

All 7 trials loaded